Targeted News Service

Goodwin Advises Ascidian Therapeutics on Entering Strategic Agreement With Exegenesis Bio
November 13, 2026

BOSTON, Massachusetts, Nov. 13 [Category: BizLaw/Legal] -- Goodwin, a law firm, posted the following news release:

* * *

Goodwin Advises Ascidian Therapeutics on Entering Strategic Agreement With Exegenesis Bio

*

The Life Sciences team advised Ascidian Therapeutics on its strategic agreement with Exegenesis Bio, a global gene therapy company with proprietary AI-enabled optimized adeno-associated virus capsid discovery capabilities. The strategi . . .

Targeted News Service Document Request Form

This document is available to you by e-mail if you complete the form below with relevant information. There may be a fee for this article or ongoing service of similar materials. We will be in touch shortly.

Click here for more information about our products

Existing Customer Login

Targeted News Service Document Request Form